Skip to main navigation Skip to search Skip to main content

Severe Acute Respiratory Syndrome Coronavirus 2 Evolution and Escape from Combination Monoclonal Antibody Treatment in a Person with HIV

  • Dara Khosravi
  • , Hannah Soloff
  • , Rose M. Langsjoen
  • , Andrei Bombin
  • , Colleen F. Kelley
  • , Susan M. Ray
  • , Clifford J. Gunthel
  • , Brian C. Zanoni
  • , Phuong Vi Nguyen
  • , Jesse J. Waggoner
  • , Yun F. Wang
  • , Valeria D. Cantos
  • , Anne Piantadosi

Research output: Contribution to journalArticlepeer-review

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from combination monoclonal antibody treatment is rarely reported. We describe an immunocompromised individual with human immunodeficiency virus and persistent SARS-CoV-2 infection in whom substantial SARS-CoV-2 evolution occurred, including the emergence of 2 mutations associated with escape from the monoclonal antibody cocktail received.

Original languageEnglish (US)
Article numberofad054
JournalOpen Forum Infectious Diseases
Volume10
Issue number2
DOIs
StatePublished - Feb 1 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HIV
  • SARS-CoV-2
  • immunocompromised
  • monoclonal antibody
  • virus evolution

ASJC Scopus subject areas

  • Oncology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Severe Acute Respiratory Syndrome Coronavirus 2 Evolution and Escape from Combination Monoclonal Antibody Treatment in a Person with HIV'. Together they form a unique fingerprint.

Cite this